William E. Kennard - 10 Mar 2026 Form 4 Insider Report for METLIFE INC (MET)

Role
Director
Signature
/s/ Taylor McInerney Jansen, Attorney-in-fact
Issuer symbol
MET
Transactions as of
10 Mar 2026
Net transactions value
$0
Form type
4
Filing time
12 Mar 2026, 16:07:30 UTC
Previous filing
04 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kennard William E Director METLIFE, INC., 200 PARK AVENUE, NEW YORK /s/ Taylor McInerney Jansen, Attorney-in-fact 12 Mar 2026 0001198236

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MET Common Stock Award +365 +0.8% $70.60* 45,780 10 Mar 2026 Direct F1
holding MET Common Stock 10 10 Mar 2026 By the MetLife Policyholder Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.
F2 Shares held in trust under the MetLife Policyholder Trust established to hold shares of common stock allocated to eligible policyholders of Metropolitan Life Insurance Company, a wholly-owned subsidiary of MetLife, Inc.